Raymond James initiated coverage on shares of Integer (NYSE:ITGR - Free Report) in a report released on Friday morning, MarketBeat Ratings reports. The brokerage issued an outperform rating and a $145.00 target price on the medical equipment provider's stock.
Other equities analysts have also recently issued research reports about the company. Wells Fargo & Company reissued an "overweight" rating and set a $160.00 price target on shares of Integer in a report on Tuesday, December 3rd. Oppenheimer lowered Integer from an "outperform" rating to a "market perform" rating in a research report on Friday, February 21st. KeyCorp increased their price objective on shares of Integer from $144.00 to $154.00 and gave the stock an "overweight" rating in a research report on Friday, January 24th. Citigroup raised their price objective on shares of Integer from $130.00 to $145.00 and gave the company a "neutral" rating in a research note on Wednesday, December 11th. Finally, Benchmark lifted their price objective on shares of Integer from $140.00 to $150.00 and gave the stock a "buy" rating in a report on Friday, February 21st. Two analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. According to MarketBeat, Integer presently has a consensus rating of "Moderate Buy" and an average target price of $148.56.
Check Out Our Latest Stock Analysis on ITGR
Integer Stock Up 0.8 %
NYSE ITGR traded up $0.98 during trading hours on Friday, reaching $118.99. 177,724 shares of the company's stock were exchanged, compared to its average volume of 326,714. The company's 50-day moving average is $130.01 and its two-hundred day moving average is $132.03. The company has a debt-to-equity ratio of 0.62, a quick ratio of 2.09 and a current ratio of 2.95. Integer has a one year low of $107.11 and a one year high of $146.36. The company has a market capitalization of $4.00 billion, a price-to-earnings ratio of 35.41, a price-to-earnings-growth ratio of 1.72 and a beta of 1.24.
Integer (NYSE:ITGR - Get Free Report) last announced its quarterly earnings results on Thursday, February 20th. The medical equipment provider reported $1.43 EPS for the quarter, missing analysts' consensus estimates of $1.46 by ($0.03). The firm had revenue of $449.50 million during the quarter, compared to analyst estimates of $446.28 million. Integer had a net margin of 6.92% and a return on equity of 11.65%. On average, analysts forecast that Integer will post 6.01 EPS for the current fiscal year.
Hedge Funds Weigh In On Integer
Several institutional investors have recently bought and sold shares of ITGR. Capital Research Global Investors raised its holdings in shares of Integer by 16.0% in the fourth quarter. Capital Research Global Investors now owns 1,410,803 shares of the medical equipment provider's stock worth $186,960,000 after buying an additional 194,895 shares during the period. Geode Capital Management LLC lifted its holdings in shares of Integer by 1.2% during the 3rd quarter. Geode Capital Management LLC now owns 764,528 shares of the medical equipment provider's stock valued at $99,408,000 after purchasing an additional 9,421 shares during the last quarter. Loomis Sayles & Co. L P increased its holdings in shares of Integer by 3.8% during the fourth quarter. Loomis Sayles & Co. L P now owns 558,715 shares of the medical equipment provider's stock valued at $74,041,000 after acquiring an additional 20,688 shares in the last quarter. Congress Asset Management Co. increased its stake in Integer by 2.0% during the 4th quarter. Congress Asset Management Co. now owns 498,350 shares of the medical equipment provider's stock valued at $66,041,000 after purchasing an additional 9,565 shares in the last quarter. Finally, Driehaus Capital Management LLC raised its stake in Integer by 5.5% in the 4th quarter. Driehaus Capital Management LLC now owns 451,464 shares of the medical equipment provider's stock worth $59,828,000 after acquiring an additional 23,706 shares during the last quarter. 99.29% of the stock is owned by hedge funds and other institutional investors.
Integer Company Profile
(
Get Free Report)
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
Read More
Before you consider Integer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integer wasn't on the list.
While Integer currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
